The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathologic responses have yet to be fully identified. We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA1, are markedly protected from fibrosis and mortality in this model. The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury. In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid. LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bexotegrast is a small molecule dual inhibitor of αvβ6 and αvβ1[105]. Cumulative data of 630 patients composed of several phase 1 and 2 trials investigating αvβ6 and αvβ1 in both IPF and primary sclerosing cholangitis demonstrated mild adverse effects in the bexotegrast group (headache, diarrhea, and nausea), with diarrhea being the most common in phase 2 studies”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [104]
In the citing paper
“In pulmonary fi brosis, lysophosphatidic acid receptor 1 (LPA1) activation is associated with fi broblast recruitment, activation/proliferation, and survival, as well as epithelial cell apoptosis, all of which drive lung fi brosis progression (8, 9).”
From Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial. (2025) · cites this paper as [8]
In the citing paper
“LPA1 is known to be involved in in fl ammatory responses of vascular endothelium and fi broblast recruitment”
From Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial. (2025) · cites this paper as [8]
In the citing paper
“and LPA1 de fi ciency attenuated fi broblast recruitment in a murine model of lung fi brosis (8).”
From Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial. (2025) · cites this paper as [8]
Citations
Cites
Wound Healing--Aiming for Perfect Skin Regeneration
Martin, P. (1997) · Science · doi:10.1126/science.276.5309.75 · Cited by 4,804 · cited 1×
“After cutaneous injury, fibroblasts migrate into the provisional fibrin matrix of the wound clot during granulation tissue formatio”
BackgroundRidley, A. J., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90163-7 · Cited by 4,468
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630 · cited 1×
“1a ), indicating that the relevant fibroblast receptor(s) signal through the Gα i class of G proteins, a hallmark of the chemoattractant subfamily of GPCR”
BackgroundSelf-citationMunger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853 · cited 1×
“Epigenetic processes, such as DNA or histone methylation and histone acetylation, produce heritable but potentially reversible changes in DNA or its associated proteins, and are prominent in developmental processes and oncogenesis ( 1 ).”
BackgroundSelman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786 · cited 1×
“In the lung, aberrant wound-healing responses to injury are thought to contribute to the pathogenesis of idiopathic pulmonary fibrosis (IPF”
BackgroundSelf-citationCirculating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257 · cited 1×
“Fibrin deposition in injured airspaces may contribute to fibroblast accumulation both by providing a provisional matrix for fibroblast migration and by promoting epithelial-to-mesenchymal transitio”
BackgroundThe emerging role of lysophosphatidic acid in cancer
Mills, G. B., & Moolenaar, W. H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1143 · Cited by 1,094 · cited 1×
“LPA has been shown to induce the invasion of cancer cells across tissue barriers, promoting metastasi”
BackgroundCirculating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079 · cited 1×
“We and others have reported evidence that inhibition of fibroblast migration can attenuate pulmonary fibrosi”
BackgroundIdentification and characterization of a fibroblast marker: FSP1.
Strutz, F., Okada, H., Lo, C. W., Danoff, T., Carone, R. L., Tomaszewski, J. E., & Neilson, E. G. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.2.393 · Cited by 1,077 · cited 1×
“We then quantified fibroblast accumulation in wild-type and LPA 1 -deficient mice by staining with antibody to fibroblast-specific protein 1 (FSP1”
MethodLysophospholipid Receptors: Signaling and Biology
Ishii, I., Fukushima, N., Ye, X., & Chun, J. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073731 · Cited by 771 · cited 1×
“LPA signals through at least five GPCRs designated LPA 1–5 (refs”
BackgroundSelf-citationNoguchi, K., Ishii, S., & Shimizu, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302648200 · Cited by 557 · cited 1×
“LPA signals through at least five GPCRs designated LPA 1–5 (refs”
BackgroundFatty acid binding to human serum albumin: new insights from crystallographic studies
Curry, S., Brick, P., & Franks, N. P. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00148-1 · Cited by 495 · cited 1×
“Albumin transports lipids, which it binds through hydrophobic interaction”
BackgroundProtective Effects of Sphingosine 1-Phosphate in Murine Endotoxin-induced Inflammatory Lung Injury
Peng, X., Hassoun, P. M., Sammani, S., McVerry, B. J., Burne, M. J., Rabb, H., Pearse, D., Tuder, R. M., & Garcia, J. G. N. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1258oc · Cited by 495 · cited 1×
“In this regard, LPA acts in opposition to another lysophospholipid, S1P, which reduces vascular leak after lung injur”
BackgroundZhang, K., Rekhter, M. D., Gordon, D., & Phan, S. H. (1994) · PubMed · Cited by 480
Requirement for the lp A1 lysophosphatidic acid receptor gene in normal suckling behavior
Contos, J. J. A., Fukushima, N., Weiner, J. A., Kaushal, D., & Chun, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13384 · Cited by 479 · cited 1×
“To further test this hypothesis and examine the role of LPA-directed fibroblast recruitment in vivo , we obtained mice genetically deficient for LPA 1 (ref”
BackgroundSelf-citationGPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5
Lee, C.-W., Rivera, R., Gardell, S., Dubin, A. E., & Chun, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603670200 · Cited by 471 · cited 1×
“LPA signals through at least five GPCRs designated LPA 1–5 (refs”
BackgroundSelf-citationKuhn, C., Boldt, J., King, T. E., Crouch, E., Vartio, T., & McDonald, J. A. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.6.1693 · Cited by 466
Boucharaba, A., Serre, C.-M., Grès, S., Saulnier-Blache, J. S., Bordet, J.-C., Guglielmi, J., Clézardin, P., & Peyruchaud, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422123 · Cited by 462 · cited 1×
“Several processes induced by lung injury may contribute to increased levels of LPA in the airspaces, including platelet activatio”
BackgroundCCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., & Toews, G. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62289-4 · Cited by 441
Means, T. K., Hayashi, F., Smith, K. D., Aderem, A., & Luster, A. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5165 · Cited by 410
Self-citationKi16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors
Ohta, H., Sato, K., Murata, N., Damirin, A., Malchinkhuu, E., Kon, J., Kimura, T., Tobo, M., Yamazaki, Y., Watanabe, T., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.994 · Cited by 402 · cited 1×
“34 μM for LPA 1 , without appreciable effects on receptors of closely related lipids, such as sphingosine 1-phosphate (S1P”
BackgroundCoagulation, fibrinolysis, and fibrin deposition in acute lung injury
Idell, S. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057846.21303.ab · Cited by 381
Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung
Reutershan, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27009 · Cited by 322 · cited 1×
“We assessed extravasation of Evans blue dye using a technique modified from a previously published techniqu”
MethodThe Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis
Moore, B. B., Murray, L., Das, A., Wilke, C. A., Herrygers, A. B., & Toews, G. B. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0239oc · Cited by 309 · cited 1×
“We and others have reported evidence that inhibition of fibroblast migration can attenuate pulmonary fibrosi”
BackgroundHama, K., Aoki, J., Fukaya, M., Kishi, Y., Sakai, T., Suzuki, R., Ohta, H., Yamori, T., Watanabe, M., Chun, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313927200 · Cited by 276 · cited 1×
“1h ), which has been shown to mediate LPA-induced chemotaxis of mouse embryonic fibroblast”
BackgroundSelf-citationKim, N. D., Chou, R. C., Seung, E., Tager, A. M., & Luster, A. D. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052349 · Cited by 273 · cited 1×
“We isolated >90% pure populations of mature neutrophils from the bone marrow of unchallenged C57Bl/6 mice by centrifugation over discontinuous Percoll gradients as previously describe”
MethodSelf-citationAccelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern
Selman, M., Carrillo, G., Estrada, A., Mejia, M., Becerril, C., Cisneros, J., Gaxiola, M., Pérez-Padilla, R., Navarro, C., Richards, T., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000482 · Cited by 270 · cited 1×
“A pathogenic role for fibroblast migration in IPF is further supported by the recent description of an accelerated variant of IP”
BackgroundSelf-citationDifferential expression of homing-associated adhesion molecules by T cell subsets in man.
Picker, L. J., Terstappen, L. W. M. M., Rott, L. S., Streeter, P. R., Stein, H., & Butcher, E. C. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3247 · Cited by 262
Intraluminal fibrosis in interstitial lung disorders.
Basset, F., Ferrans, V. J., Soler, P., Takemura, T., Fukuda, Y., & Crystal, R. G. (1986) · PubMed Central · Cited by 249
Hara, T., Jung, L. K., Bjorndahl, J. M., & Fu, S. M. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.6.1988 · Cited by 242 · cited 1×
“The percentages BAL CD4 + and CD8 + T cells that had recently been activated, as indicated by CD69 expressio”
BackgroundXiao, Y.-J., Schwartz, B., Washington, M., Kennedy, A., Webster, K., Belinson, J., & Xu, Y. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5000 · Cited by 232 · cited 1×
“An investigator blinded to the identity of the samples determined BAL total LPA concentrations by electrospray ionization mass spectrometry (ESI-MS) as previously describe”
MethodSelf-citationLoss of Fibroblast Thy-1 Expression Correlates with Lung Fibrogenesis
Hagood, J. S., Prabhakaran, P., Kumbla, P., Salazar, L., MacEwen, M. W., Barker, T. H., Ortiz, L. A., Schoeb, T., Siegal, G. P., Alexander, C. B., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62982-3 · Cited by 226 · cited 1×
“We showed that Thy-1 expression suppresses myofibroblastic differentiation of lung fibroblasts (2), and that fibroblasts in FF of IPF are Thy-1(2) ( 3 ).”
BackgroundSelf-citationInhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10
Tager, A. M., Kradin, R. L., LaCamera, P., Bercury, S. D., Campanella, G. S. V., Leary, C. P., Polosukhin, V., Zhao, L.-H., Sakamoto, H., Blackwell, T. S., et al. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0175oc · Cited by 199 · cited 1×
“We and others have reported evidence that inhibition of fibroblast migration can attenuate pulmonary fibrosi”
BackgroundSelf-citationRapid flow cytometric method for measuring lymphocyte subset activation
Maino, V. C., Suni, M. A., & Ruitenberg, J. J. (1995) · Cytometry · doi:10.1002/cyto.990200205 · Cited by 197 · cited 1×
“The percentages BAL CD4 + and CD8 + T cells that had recently been activated, as indicated by CD69 expressio”
BackgroundRole of RhoA and Rho Kinase in Lysophosphatidic Acid–Induced Endothelial Barrier Dysfunction
Amerongen, G. P. V. N., Vermeer, M. A., & van Hinsbergh, V. W. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.e127 · Cited by 173 · cited 1×
“LPA also induces endothelial cell barrier dysfunction and vascular lea”
BackgroundCharacterization of Fibroblast-specific Protein 1 in Pulmonary Fibrosis
Lawson, W. E., Polosukhin, V. V., Zoia, O., Stathopoulos, G. T., Han, W., Plieth, D., Loyd, J. E., Neilson, E. G., & Blackwell, T. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200311-1535oc · Cited by 173 · cited 1×
“Immunohistochemistry previously performed with this antibody specifically stained interstitial cells that coexpressed procollagen type 1 α 1 (ref”
BackgroundSelf-citationEnhanced Myofibroblastic Differentiation and Survival in Thy-1(−) Lung Fibroblasts
Sanders, Y. Y., Kumbla, P. A., & Hagood, J. S. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0178oc · Cited by 159 · cited 1×
“We showed that Thy-1 expression suppresses myofibroblastic differentiation of lung fibroblasts ( 2 ), and that fibroblasts in FF of IPF are Thy-1(2) (3).”
BackgroundLung, H. L., Bangarusamy, D., Xie, D., Cheung, A., Cheng, Y., Kumaran, M., Miller, L., Liu, E., Guan, X., Sham, J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208812 · Cited by 135
Allport, J. R., Lim, Y.-C., Shipley, J. M., Senior, R. M., Shapiro, S. D., Matsuyoshi, N., Vestweber, D., & Luscinskas, F. W. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.5.821 · Cited by 133 · cited 1×
“We isolated primary lung endothelial cells by sequential selection with PECAM-1–specific and ICAM-2–specific monoclonal antibody–coated magnetic beads according to a published protoco”
MethodGelsolin Binding and Cellular Presentation of Lysophosphatidic Acid
Goetzl, E. J., Lee, H., Azuma, T., Stossel, T. P., Turck, C. W., & Karliner, J. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14573 · Cited by 129 · cited 1×
“In addition to the regulation of LPA concentration, however, LPA activity is also regulated by its binding to proteins that can either sequester it or increase its delivery to its receptor”
BackgroundNeidlinger, N. A., Larkin, S. K., Bhagat, A., Victorino, G. P., & Kuypers, F. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505790200 · Cited by 111 · cited 1×
“LPA also induces endothelial cell barrier dysfunction and vascular lea”
BackgroundCoagulation cascade proteases and tissue fibrosis
Chambers, R. C., & Laurent, G. J. (2001) · Biochemical Society Transactions · doi:10.1042/bst0300194 · Cited by 108 · cited 1×
“One consequence of the persistent vascular leak induced by lung injury that may contribute to the development of fibrosis is extravascular coagulatio”
BackgroundPhosphatidic Acid and Lysophosphatidic Acid Induce Haptotactic Migration of Human Monocytes
Zhou, D., Luini, W., Bernasconi, S., Diomede, L., Salmona, M., Mantovani, A., & Sozzani, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25549 · Cited by 101
Heise, C. E., Santos, W. L., Schreihofer, A. M., Heasley, B. H., Mukhin, Y. V., Macdonald, T. L., & Lynch, K. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1173 · Cited by 99
Goetzl, E. J., Kong, Y., & Voice, J. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4996 · Cited by 95
Medoff, B. D., Seung, E., Wain, J. C., Means, T. K., Campanella, G. S. V., Islam, S. A., Thomas, S. Y., Ginns, L. C., Grabie, N., Lichtman, A. H., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042481 · Cited by 67 · cited 1×
“We performed these bronchoscopies both at the Instituto Nacional de Enfermedades Respiratorias (INER), Mexico and the Massachusetts General Hospital (MGH), as previously describe”
MethodSelf-citationChanges in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases
Honda, Y., Tsunematsu, K., Suzuki, A., & Akino, T. (1988) · Lung · doi:10.1007/bf02714060 · Cited by 58
Sugimoto, N., Takuwa, N., Yoshioka, K., & Takuwa, Y. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.02.020 · Cited by 43 · cited 1×
“Chemotactic indices of PTX-treated fibroblasts induced by LPA were actually less than 1, consistent with recently described LPA-mediated inhibition of cell migration through Gα 12/13 -coupled signaling when Gα i -coupled signaling is inhibited by PT”
BackgroundMorphological and Biochemical Properties of Alveolar Fibroblasts in Interstitial Lung Diseases
Fireman, E. M., Shahar, I., Shoval, S., Messer, G., Dvash, S., & Grief, J. (2001) · Lung · doi:10.1007/s004080000051 · Cited by 33
Behr, J., Adelmann-Grill, B. C., Krombach, F., Beinert, T., Schwaiblmair, M., & Fruhmann, G. (1993) · Thorax · doi:10.1136/thx.48.7.736 · Cited by 28 · cited 1×
“Fibroblast chemoattractant activity is generated in the airspaces in IPF, and its extent correlates with disease severit”
BackgroundDiNubile, M. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00007.2007 · Cited by 22 · cited 1×
“Plasma gelsolin levels decline after tissue injury, and increased LPA activity due to plasma gelsolin depletion has been hypothesized to exacerbate organ dysfunction in this settin”
Background
Cited by
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
“Antagonists of the lysophosphatidic acid-1 receptor, a growth factor that induces CTGF and TGF-β 1 expression, are being considered as treatments for kidney fibrosis, IPF and systemic sclerosis 159,160 .”
Integrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
“The lysophosphatidic acid receptor 1 also controls the recruitment of fibroblasts in mice with bleomycin-induced fibrosis and levels of lysophosphatidic acid are increased in the BAL fluid of people with IPF (Tager et al., 2008).”
BackgroundMechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2014 · Cited by 874
Self-citationLPA Receptors: Subtypes and Biological Actions
Choi, J. W., Herr, D. R., Noguchi, K., Yung, Y. C., Lee, C.-W., Mutoh, T., Lin, M.-E., Teo, S. T., Park, K. E., Mosley, A. N., et al. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105753 · Cited by 839
Self-citationFeedback amplification of fibrosis through matrix stiffening and COX-2 suppression
Liu, F., Mih, J. D., Shea, B. S., Kho, A. T., Sharif, A. S., Tager, A. M., & Tschumperlin, D. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201004082 · Cited by 810
“C57BL/6 mice (The National Cancer Institute Animal Production Program) were instilled intratracheally with 0.05 U bleomycin (Gensia Sicor Pharmaceuticals Inc.) in 50 µl sterile saline or with 50 µl sterile saline for control mice, with lung tissue harvested 14 d later (Tager et al., 2008).”
InfluentialSelf-citation
Metadata
- Authors
- Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., Hart, W. K., Pardo, A., Blackwell, T. S., Xu, Y., Chun, J., & Luster, A. D.
- Affiliations
- Harvard University (US)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- Indiana University Indianapolis (US)
- Vanderbilt University (US)
- Universidad Nacional Autónoma de México (MX)
- Scripps Research Institute (US)
- Corresponding author
- Luster, Andrew D
- ORCID
- Venue
- Nature Medicine
- Published
- 2007-12-09
- Volume
- 14
- Issue
- 1
- Pages
- 45-54
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2131032222
- Cited by
- 823
- References
- 54
- Citations by year
- 2026: 24 · 2025: 49 · 2024: 50 · 2023: 49 · 2022: 51 · 2021: 61 · 2020: 55 · 2019: 38 · 2018: 36 · 2017: 47 · 2016: 49 · 2015: 41 · 2014: 51 · 2013: 49 · 2012: 53
- FWCI
- 23.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Lung Association
- National Institutes of Health (5r01ca069212-18)
- National Institute of Mental Health (K02 MH01723, R01MH051699, K02MH001723, R01MH-51699)
- National Cancer Institute (R01CA69212, R01-CA89228, R01CA095042, R01CA089228)
- National Institute of Neurological Disorders and Stroke (R01NS048478)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- lysophosphatidic acid, LPA1 receptor, pulmonary fibrosis, idiopathic pulmonary fibrosis, lung injury, fibroblast recruitment, vascular leakage, bleomycin-induced fibrosis, bronchoalveolar lavage fluid, wound healing, chemotaxis, therapeutic target
- MeSH terms
- Animals, Bleomycin, Bronchoalveolar Lavage Fluid, Female, Fibroblasts, Leukocytes, Lung, Lysophospholipids, Male, Mice, Inbred C57BL, Models, Biological, Pulmonary Fibrosis, Mice, Knockout, Receptors, Lysophosphatidic Acid, Mice, Lung Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.